Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Venture Growth Investments (JVGI) is a Japanese venture capital firm headquartered in Tokyo, established as a wholly-owned subsidiary of Mitsubishi UFJ Capital. The firm manages the Japan Venture Growth Fund, which focuses on providing significant growth-stage capital to Japanese startups across diverse sectors, including healthcare, biotechnology, and information technology. JVGI's primary mission is to support late-stage ventures in their transition toward initial public offerings or strategic exits. By leveraging the network and financial expertise of the Mitsubishi UFJ Financial Group (MUFG), the company provides both capital and strategic advisory services to its portfolio companies. The firm aims to address the funding gap in the Japanese ecosystem for middle-to-late stage companies, helping them scale and compete globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Venture Growth Investments.